MacroGenics
MGNX
#8210
Rank
NZ$0.47 B
Marketcap
NZ$7.45
Share price
2.35%
Change (1 day)
177.73%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): NZ-$0.20

According to MacroGenics's latest financial reports the company's current EPS (TTM) is NZ-$0.08558. In 2024 the company made an earnings per share (EPS) of NZ-$1.83 a decrease over its 2023 EPS that were of NZ-$0.26.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.20-89.21%
2024NZ-$1.83613.33%
2023NZ-$0.26-92.31%
2022NZ-$3.34-42.14%
2021NZ-$5.7736.44%
2020NZ-$4.23-21.84%
2019NZ-$5.41-24.58%
2018NZ-$7.17675.93%
2017NZ-$0.92-68.05%
2016NZ-$2.89168.25%
2015NZ-$1.08-55%
2014NZ-$2.403400%
2013NZ-$0.06846-108.68%
2012NZ$0.7924.49%
2011NZ$0.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.24-2,720.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.31-56,550.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.78-29,060.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.72-13,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.09-7,214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.09-7,220.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ-$3.03 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA